Nasdaq
NNNN
Anbio Biotechnology
- Health Care
- Germany
- Listed 2025
- 1 day
- −3.9%
- 1 month
- −16.7%
- 1 year
- −78.1%
$9.75 · Mkt cap $1.40B · P/E 66.33
At the 6 Aug 2026 close
Nasdaq
Anbio Biotechnology
$9.75 · Mkt cap $1.40B · P/E 66.33
At the 6 Aug 2026 close
Anbio Biotechnology trades under the ticker NNNN on Nasdaq, in the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances). It has been listed since 2025. Its market capitalisation is $1.40B. The last closing price was $9.75, on 6 Aug 2026. It trades at 66.33 times its last reported annual diluted earnings per share. Over the past year the share price is −78.1%, and −16.7% over the past month. Returns are price returns and exclude dividends.
This page exists because NNNN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.